Aardvark Therapeutics’ Insider Surge: Executives Buy 44,964 Options in Bold Vote of Confidence Amid Market Volatility
Inside Aardvark Therapeutics: insiders buy 44,964 options, signaling confidence amid volatility and a hopeful rebound as the company re‑prices its plans.
3 minutes to read

